CERVICAL CANCER SCREENING IN OLDER WOMEN
老年女性的宫颈癌筛查
基本信息
- 批准号:2748947
- 负责人:
- 金额:$ 7.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-08-08 至 2001-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Applicant's Description): George F. Sawaya, M.D. is a
full-time faculty member in the Department of Obstetrics, Gynecology and
Reproductive Sciences at the University of California, San Francisco (UCSF).
Dr. Sawaya's main interest is in evidence-based medicine, especially as it
pertains to women's health. He has recently completed a two-year fellowship
in epidemiology, biostatistics and research design at UCSF. Specifically,
he is interested in cervical cancer screening in older women. He is
strongly committed to an academic career in women's health.
This proposal has four specific aims: 1) to determine the efficacy of
cervical smear screening in preventing invasive cervical cancer in women
>60, 2) to determine differences in compliance and disease characteristics
between women >60 compared to women <60 diagnosed with invasive cervical
cancer, 3) to d e t e r mine the annual incidence of cervical smear
abnormalities in postmenopausal women, and 4) to determine risk factors,
including use of hormonal replacement therapy, for developing cervical smear
abnormalities in postmenopausal women. The first two aims will be achieved
by analyzing data from the Kaiser Permanente Cervical Cancer Project. This
database contains cervical smear information on 649 women diagnosed with
invasive cervical cancer from 1988-1994, 130 of whom are aged 60 and older.
The two studies using this dataset are designed to provide information on
differences in compliance, disease characteristics and protection afforded
by cervical smear screening between older women and younger women. The
second and third aims will be achieved by analyzing existing data from the
Heart Estrogen-progestin Study, a randomized, placebo-controlled trial of
hormonal replacement therapy (HRT) in 2763 postmenopausal women. All women
had normal cervical smears at trial entry and are screened annually.
Determination of the incidence of smear abnormalities in this population is
crucial to cost-effectiveness and decision analyses of screening protocols.
Identification of risk factors would allow for more targeted screening and
fewer false positive smears. Moreover, the independent risk of HRT will be
assessed.
Dr. Sawaya has assembled a multidisciplinary team of nationally-known
sponsors who are enthusiastic about his research plan and are committed to
his successful completion of this project. They are dedicated to assisting
him in achieving his goal of becoming an excellent clinical investigator.
描述(申请人描述):George F.Sawaya,医学博士
妇产科全职教员
加州大学旧金山分校(UCSF)生殖科学专业。
Sawaya博士的主要兴趣是循证医学,特别是它
与女性的健康有关。他最近完成了一项为期两年的奖学金。
加州大学旧金山分校的流行病学、生物统计学和研究设计。具体来说,
他对老年女性的宫颈癌筛查很感兴趣。他是
坚定地致力于妇女健康方面的学术事业。
这项建议有四个具体目标:1)确定
宫颈涂片筛查在预防妇女浸润性宫颈癌中的作用
>;60,2)确定依从性和疾病特征的差异
女性与被诊断为宫颈侵袭性疾病的女性之间的比较
癌症,3)降低宫颈涂片的年发病率
绝经后妇女的异常,以及4)确定危险因素,
包括使用激素替代疗法,以进行宫颈涂片
绝经后妇女的异常。前两个目标将会实现
通过分析Kaiser Permanente子宫颈癌项目的数据。这
数据库包含649名被诊断患有子宫颈疾病的妇女的宫颈涂片信息
1988-1994年的浸润性宫颈癌,其中130人年龄在60岁及以上。
使用此数据集的两项研究旨在提供以下信息
遵从性、疾病特征和提供的保护方面的差异
通过对老年妇女和年轻妇女进行宫颈涂片筛查。这个
第二和第三个目标将通过分析来自
心脏雌激素-孕激素研究,一项随机、安慰剂对照试验
2763例绝经后妇女激素替代治疗。所有女性
在试验开始时进行了正常的宫颈涂片检查,并每年进行筛查。
该人群中涂片异常发生率的确定为
对筛查方案的成本效益和决策分析至关重要。
识别风险因素将允许进行更有针对性的筛查和
更少的假阳性涂片。此外,HRT的独立风险将是
评估过了。
Sawaya博士组建了一支多学科团队,
对他的研究计划充满热情并致力于
他成功地完成了这个项目。他们致力于协助
他在实现成为一名优秀的临床研究员的目标方面发挥了重要作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE F SAWAYA其他文献
GEORGE F SAWAYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE F SAWAYA', 18)}}的其他基金
Cervical cancer screening after age 65 in the era of HPV testing: estimating benefits and harms of screening cessation and continuation
HPV检测时代65岁以后的宫颈癌筛查:评估停止和继续筛查的利弊
- 批准号:
10670421 - 财政年份:2022
- 资助金额:
$ 7.4万 - 项目类别:
Using comparative effectiveness analyses to optimize cervical cancer screening
使用比较有效性分析来优化宫颈癌筛查
- 批准号:
8458450 - 财政年份:2013
- 资助金额:
$ 7.4万 - 项目类别:
Using comparative effectiveness analyses to optimize cervical cancer screening
使用比较有效性分析来优化宫颈癌筛查
- 批准号:
9025563 - 财政年份:2013
- 资助金额:
$ 7.4万 - 项目类别:
Using comparative effectiveness analyses to optimize cervical cancer screening
使用比较有效性分析来优化宫颈癌筛查
- 批准号:
8819034 - 财政年份:2013
- 资助金额:
$ 7.4万 - 项目类别:














{{item.name}}会员




